New steroidal 17β-carboxy derivatives present anti-5α-reductase activity and anti-proliferative effects in a human androgen-responsive prostate cancer cell line-Reference-Cited by-同舟云学术

New steroidal 17β-carboxy derivatives present anti-5α-reductase activity and anti-proliferative effects in a human androgen-responsive prostate cancer cell line

Published:2013-11 Issue:11 Volume:95 Page:2097-2106
ISSN:0300-9084
Container-title:Biochimie
language:en
Short-container-title:Biochimie

Author:

Amaral Cristina,Varela Carla,Correia-da-Silva Georgina,Tavares da Silva Elisiário,Carvalho Rui A.,Costa Saul C.P.,Cunha Sara C.,Fernandes José O.,Teixeira Natércia,Roleira Fernanda M.F.

Publisher

Elsevier BV

Subject

General Medicine,Biochemistry

Reference41 articles.

1. Global cancer statistics;Jemal;CA Cancer J. Clin.,2011

2. Molecular basis of steroid action in the prostate;Zhu;Cellscience,2005

3. 5alpha-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction;Rittmaster;Best Pract. Res. Clin. Endocrinol. Metab.,2008

4. 5alpha-reductase isozymes and androgen actions in the prostate;Zhu;Ann. N. Y. Acad. Sci.,2009

5. The 5 alpha-reductase isozyme family: a review of basic biology and their role in human diseases;Azzouni;Adv. Urol.,2012

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Structural Diversity and Biological Activity of Steroid Oximes;Molecules;2023-02-10

2. High altitude exposure affects male reproductive parameters: could it also affect the prostate?;Biology of Reproduction;2021-11-01

3. The potential clinical benefit of targeting androgen receptor (AR) in estrogen-receptor positive breast cancer cells treated with Exemestane;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2020-05

4. Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors;ASSAY and Drug Development Technologies;2019-03

5. Design, synthesis and biological evaluation of novel androst-3,5-diene-3-carboxylic acid derivatives as inhibitors of 5α-reductase type 1 and 2;Steroids;2017-08